Peter S. Garcia - Aug 5, 2022 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
Chief Financial Officer
Signature
/s/ Peter Garcia
Stock symbol
ALXO
Transactions as of
Aug 5, 2022
Transactions value $
$0
Form type
4
Date filed
8/9/2022, 05:57 PM
Previous filing
Jun 17, 2022
Next filing
Jan 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Award $0 +29K +110.78% $0.00 55.2K Aug 5, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Employee Stock Option (right to buy) Award $0 +95K $0.00 95K Aug 5, 2022 Common Stock 95K $11.47 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2022.
F2 Includes 1,695 shares acquired under the Issuer's employee stock purchase plan on June 30, 2022.
F3 Shares subject to the option vest in 48 equal monthly installments beginning on August 1, 2022.